Client News

Posted: January 20, 2017, 10:50 pm
Posted: January 20, 2017, 3:12 pm
[GlobeNewswire] - NEW YORK, Jan. 20, 2017-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the pricing of an underwritten public offering ...
Posted: January 20, 2017, 2:00 pm
[GlobeNewswire] - HAIFA, Israel, Jan. 20, 2017-- Pluristem Therapeutics Inc. announced today that due to increased demand, it has entered into an amended and restated underwriting agreement with H.C. Wainwright & Co., LLC, ...
Posted: January 20, 2017, 12:00 pm
[GlobeNewswire] - HAIFA, Israel, Jan. 19, 2017-- Pluristem Therapeutics Inc. announced today that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC, under which the underwriter has agreed to ...
Posted: January 19, 2017, 9:53 pm
[GlobeNewswire] - NEW YORK, Jan. 19, 2017-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced that it intends to offer and sell, subject to market ...
Posted: January 19, 2017, 9:04 pm
[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Alcobra, Ltd. concerning possible violations of federal securities laws.
Posted: January 19, 2017, 4:05 pm
Posted: January 19, 2017, 12:42 pm
Posted: January 19, 2017, 10:15 am
[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Alcobra Ltd. concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
Posted: January 18, 2017, 8:03 pm